By Stephen Nakrosis 
 

Shares of Boston Scientific Corp. are trading lower on the New York Stock Exchange Thursday, a day after the company said it launched offerings of its common stock and its Series A Mandatory Convertible preferred stock.

At 11:17 a.m. EDT, shares of the medical devices company has fallen 6.13% to trade at $34.90.

After the bell Wednesday, Boston Scientific said it commenced concurrent offerings of $750 million of shares of its common stock and $750 million of shares of its Series A Mandatory Convertible Preferred Stock.

Earlier Thursday, Fitch Ratings said Boston Scientific's ratings were unaffected by the equity issuance, and added that the issuances "will provide additional liquidity as the company experiences near-term operational pressures from the coronavirus pandemic."

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

May 21, 2020 11:40 ET (15:40 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Boston Scientific Charts.